Is ZyVersa Therapeutics Inc (ZVSA) A Good Investment?

BBAI

ZyVersa Therapeutics Inc (NASDAQ:ZVSA) finished Thursday with a subtraction of -$0.02 to close at $0.12, a downside of -9.68 percent. An average of 3,774,720 shares of common stock have been traded in the last five days. There was a fall of -$0.0049 in the past week, and it reached a new high 12 times over […]

A Peek At What ZyVersa Therapeutics Inc (ZVSA) Insiders Are Doing

ZyVersa Therapeutics Inc (NASDAQ:ZVSA) saw a downside of -4.38% to close Monday at $0.13 after subtracting $0.0 on the day. The 5-day average trading volume is 3,008,020 shares of the company’s common stock. It has gained $0.1445 in the past week and touched a new high 2 times within the past 5 days. An average […]

ZyVersa Therapeutics Inc. (ZVSA): Technical Analysis Suggests You Should Hold

The stock of ZyVersa Therapeutics Inc. (NASDAQ:ZVSA) increased by $0.01 on Tuesday to finish at $0.14, up 2.57 percent. The last five days have seen an average of 30,824,600 shares of common stock traded. 4 times new highs were reached in the current year, with a fall of -$1.4345. The average number of shares traded […]

Insights Into ZyVersa Therapeutics Inc.’s (ZVSA) Insider Activity

REV

The stock of ZyVersa Therapeutics Inc. (NASDAQ:ZVSA) decreased by $0.0 on Friday to finish at $0.15, down -1.59 percent. The last five days have seen an average of 535,420 shares of common stock traded. 4 times new highs were reached in the current year, with a fall of -$1.4214. The average number of shares traded […]